No, I read it. It doesn't mean what you think it means.
"The recent patent provides legal protection for DNAPrint's status as one of a very few companies currently capable of performing objective, assumption-free haplotype analyses."
The patent provides legal protection to DNAG for their own specific method of analysis. That's all. There is nothing 'key' about it.
Regardless of the PR spin, there are many many companies capable of doing 'haplotype analysis'. All of them have their own methods, none need to infringe on DNAG's 'proprietary' methods.
The patent essentially protects DNAG from anyone else patenting DNAG's method and thus preventing DNAG from using it. That's all it does.
A 'key' patent in this arena would be one that described a unique and exclusive method that was the 'only' way to do such an analysis. That would be something of value. Something that would require anyone who wished to perform such an analysis to have to obtain a license from DNAG in order to do it.
This is just fluff.
regards,
frog
News 
Market Data 
Discover 
AI
